cmesupplements.eyeworld.orgHome | EyeWorld

Skip to content Log in Join Search... ASCRS News Cataract Refractive Cornea Glaucoma Practice Management Non-CME Programs & Projects Corporate Replay Corporate Educational Events Supplements Menu Close ASCRS News Cataract Refractive Cornea Glaucoma Practice Management Non-CME Programs & Projects Corporate Replay Corporate Educational Events Supplements Read the March 2021 issue Update on COVID-19 vaccines The pros and cons of office-based surgery The utility of epithelial mapping Herpes zoster update Reducing postop cataract surgery drops for glaucoma patients Facility development in the peri-COVID era Read the issue Recent Articles Geoff Tabin, MD, and Sanduk Ruit, MD, selected for 2021 ASCRS Foundation Chang-Crandall Humanitarian Award The ASCRS Foundation announced Geoff Tabin, MD, and Sanduk Ruit, MD, as the 2021 Chang-Crandall Humanitarian Award winners. Endowed by a generous gift from David and Victoria Chang, the ASCRS Foundation Chang-Crandall Humanitarian Award recognizes outstanding humanitarian work with a focus on cataract blindness and disability. Performing cataract surgery with retina abnormalities When performing cataract surgery, it’s important to be aware of other conditions and comorbidities, including issues with the retina. Several physicians discussed how to handle patients with retina abnormalities prior to cataract surgery. The utility of epithelial mapping Epithelial thickness mapping was FDA approved in the U.S. in 2017, but awareness about its utility is growing. Three international ophthalmologists shared their experience with the technology and offered insights on where they think it fits in ophthalmic practices now and in the future. Demodex update: background, signs and symptoms, and treatment Demodex mites can cause a number of problems, including ocular issues. Several physicians discussed symptoms, what to look for, and ways to treat an infestation. Treatments in development were also discussed. Durysta a year later: Physicians discuss early experience Durysta, the sustained-release bimatoprost implant, 10 mcg (Allergan), has been available with FDA approval in the U.S. market for a year now. EyeWorld spoke with two physicians who started offering it as an option to their patients to hear about their experience thus far. 2021 medical marketing: The mindset practices need to attract COVID-era patients Developing a 2021 medical marketing strategy that is designed to meet the needs of patients in the COVID-19 era requires a change of mindset. Place yourself in patients’ shoes, start identifying relatable 2021 experiences, and convert those into profitable marketing opportunities, as well as chances to improve patient care. Read all articles Follow ASCRS and EyeWorld on social media: ASCRS.org EyeWorld Weekly May 28, 2021 Positive topline results in Phase 3 study for temporary presbyopia therapy Study: New therapy for ocular infections Analysis of more than half a million cataract surgeries yields PCO insights Patients blinded from AMD benefit from visual prosthetic New company focuses on refractive pharmaceutical treatments ASCRS events Read EW Weekly Archives Get the latest ophthalmology news delivered to your inbox every Friday. Sign up for the EW Weekly Archives EyeWorld Supplements EyeWorld Daily News EyeWorld Weekly EyeWorld About Contact ASCRS.org ASCRSmedia Search for: © 2021 EyeWorld News Service. All rights reserved. Legal Notice...